Town & Country Bank & Trust CO dba First Bankers Trust CO Boosts Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Town & Country Bank & Trust CO dba First Bankers Trust CO grew its stake in UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 0.8% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 5,633 shares of the healthcare conglomerate’s stock after purchasing an additional 46 shares during the period. UnitedHealth Group makes up about 1.5% of Town & Country Bank & Trust CO dba First Bankers Trust CO’s holdings, making the stock its 23rd largest holding. Town & Country Bank & Trust CO dba First Bankers Trust CO’s holdings in UnitedHealth Group were worth $2,893,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also made changes to their positions in UNH. Advocacy Wealth Management Services LLC grew its position in UnitedHealth Group by 75.8% in the first quarter. Advocacy Wealth Management Services LLC now owns 58 shares of the healthcare conglomerate’s stock worth $30,000 after acquiring an additional 25 shares during the period. Cascade Investment Advisors Inc. grew its position in UnitedHealth Group by 100.0% in the first quarter. Cascade Investment Advisors Inc. now owns 60 shares of the healthcare conglomerate’s stock worth $31,000 after acquiring an additional 30 shares during the period. Evolution Advisers Inc. purchased a new position in UnitedHealth Group in the first quarter worth approximately $38,000. Rise Advisors LLC purchased a new position in UnitedHealth Group in the fourth quarter worth approximately $38,000. Finally, Cordant Inc. purchased a new position in UnitedHealth Group in the first quarter worth approximately $45,000. 87.25% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In related news, CAO Thomas E. Roos sold 465 shares of the firm’s stock in a transaction dated Friday, August 26th. The stock was sold at an average price of $542.37, for a total transaction of $252,202.05. Following the transaction, the chief accounting officer now owns 34,786 shares of the company’s stock, valued at $18,866,882.82. The transaction was disclosed in a filing with the SEC, which is accessible through this link. In other UnitedHealth Group news, CEO Andrew Witty sold 11,376 shares of UnitedHealth Group stock in a transaction that occurred on Monday, July 18th. The stock was sold at an average price of $527.90, for a total value of $6,005,390.40. Following the sale, the chief executive officer now owns 76,559 shares of the company’s stock, valued at approximately $40,415,496.10. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CAO Thomas E. Roos sold 465 shares of UnitedHealth Group stock in a transaction that occurred on Friday, August 26th. The shares were sold at an average price of $542.37, for a total value of $252,202.05. Following the completion of the sale, the chief accounting officer now directly owns 34,786 shares in the company, valued at approximately $18,866,882.82. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 140,324 shares of company stock valued at $75,086,185. 0.40% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several research firms have recently commented on UNH. Mizuho raised their price target on UnitedHealth Group from $550.00 to $600.00 and gave the stock a “buy” rating in a research report on Wednesday, August 10th. Argus raised their price target on UnitedHealth Group from $580.00 to $650.00 and gave the stock a “buy” rating in a research report on Monday, July 25th. BMO Capital Markets raised their price target on UnitedHealth Group from $600.00 to $610.00 in a research report on Wednesday, July 20th. Oppenheimer raised their price target on UnitedHealth Group from $600.00 to $610.00 and gave the stock an “outperform” rating in a research report on Monday, July 18th. Finally, SVB Leerink increased their price objective on UnitedHealth Group from $600.00 to $625.00 and gave the company an “outperform” rating in a research note on Monday, July 18th. Three analysts have rated the stock with a hold rating, fifteen have given a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $585.65.

UnitedHealth Group Stock Down 0.1 %

UnitedHealth Group stock opened at $522.80 on Wednesday. UnitedHealth Group Incorporated has a 1-year low of $383.12 and a 1-year high of $553.29. The company has a debt-to-equity ratio of 0.60, a current ratio of 0.77 and a quick ratio of 0.77. The stock has a market cap of $489.02 billion, a PE ratio of 27.30, a P/E/G ratio of 1.64 and a beta of 0.76. The stock’s fifty day moving average is $529.42 and its two-hundred day moving average is $512.16.

UnitedHealth Group (NYSE:UNHGet Rating) last posted its quarterly earnings results on Friday, July 15th. The healthcare conglomerate reported $5.57 earnings per share for the quarter, beating analysts’ consensus estimates of $5.24 by $0.33. The company had revenue of $80.33 billion for the quarter, compared to analysts’ expectations of $79.68 billion. UnitedHealth Group had a return on equity of 25.45% and a net margin of 5.95%. UnitedHealth Group’s quarterly revenue was up 12.6% on a year-over-year basis. During the same period last year, the firm earned $4.70 earnings per share. On average, sell-side analysts expect that UnitedHealth Group Incorporated will post 21.85 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 20th. Shareholders of record on Monday, September 12th were issued a dividend of $1.65 per share. This represents a $6.60 annualized dividend and a dividend yield of 1.26%. The ex-dividend date of this dividend was Friday, September 9th. UnitedHealth Group’s payout ratio is 34.46%.

UnitedHealth Group Profile

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Featured Stories

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.